Vaxcyte Inc. (1PCVX)
MTA
51.50
0.00 (0.00%)
Closed
Oct 2, 2026
Day's Range
51.5051.50
52 wk Range
27.8055.50
Financial Statements - 1PCVX - Vaxcyte Inc.
Revenue
0
Net Income
-766.62M▼ 65.2%
EBITDA
-898.81M▼ 100.6%
Free Cash Flow
-712.55M▼ 24.6%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Sales | 0 | 0 |
| Cost of Goods | - | - |
| Gross Profit | - | - |
 Operating Expense | - | - |
| Operating Income | -923.67M | -569.54M |
| Non-Operating Interest | - | - |
| Other Income Expense | 37.32M | -4.37M |
| Pre Tax Income | -766.62M | -463.92M |
| Income Tax | - | - |
| Net Income | -766.62M | -463.92M |
| EPS Basic | -5.63 | -3.8 |
| EPS Diluted | -5.63 | -3.8 |
| Basic Shares Outstanding | 136.08M | 121.99M |
| Diluted Shares Outstanding | 136.08M | 121.99M |
| Ebit | -923.67M | -463.92M |
| Ebitda | -898.81M | -448.08M |
| Net Income Continuous Operations | -766.62M | -463.92M |
| Minority Interests | - | - |
| Preferred Stock Dividends | - | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
